DENTSPLY Sirona Inc

DENTSPLY Sirona Inc

XRAY - Insider Information

Get informed when a big investor buys or sells

+ Follow
Market Cap$1.82B
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
DENTSPLY Sirona IncDENTSPLY Sirona Inc-15.51.69%-9%0.51.7

Earnings Call Q3 2026

November 5, 2026 - AI Summary

Q3 headline performance (mixed / still pressured): - Revenue: $836M, -7.6% YoY (reported) / -7% in constant currency. - Decline driven by continued pressure in dental, including absence of Byte revenue and planned dealer inventory reductions. - Non-Byte impact: Excluding Byte-related and discrete one-time items (including planned inventory reductions), revenue declined only about -3.8% constant currency. - Profitability: Adjusted gross margin +190 bps YoY, but adjusted gross profit ~- $20M due to volume decline and higher distribution costs. - Adjusted EPS: $0.29, down $0.13 YoY.
Cash flow and capital return (negative working capital; continued buybacks): - Operating cash flow: $32M vs $79M prior year quarter (down mainly due to unfavorable working capital). - Share repurchases: 1.2M shares repurchased in Q3; $25M returned year-to-date through repurchases (second consecutive quarter). - Balance sheet: Cash/cash equivalents $195M; net debt/EBITDA 3.4x. - No dividend discussed; capital allocation emphasis remains debt reduction + buybacks.
Notable one-time/special item (surprising/technical): - Adjusted gross profit and pre-tax income benefited by about +$39M pre-tax from a change in an accounting estimate tied to improved forecasting of profit included in inventory transfers after new consolidation systems. - Management explicitly said this is multi-year in nature and not expected to recur similarly in future periods. - Included in guidance/EPS discussion: CFO indicated the benefit is effectively reflected in the updated figures (with clarification that it’s post-tax lower than the pre-tax amount).

Exclusive for Stockcircle Pro members

Sign upSign Up
$12.40

Target Price by Analysts

35.4% upsideDENTSPLY Sirona Target Price DetailsTarget Price
$17.98

Current Fair Value

96.3% upside

Undervalued by 96.3% based on the discounted cash flow analysis.

Insider Trades

Loading insider trades…

Congress Trades

Loading congress trades…

Share Statistics

Market cap$1.82 Billion
Enterprise Value$3.99 Billion
Annual dividend$0.64
Dividend yield1.69%
Earnings per Share$-3
Beta0.88
Outstanding Shares199,200,000

Return

Return on Equity-8.86%ROE
Return on Assets-2.31%
Return on Invested Capital-0.28%

Valuation & Multiples

P/E Ratio-15.51P/E Ratio
PEG15.58PEG
Price to Sales0.54Price to Sales
Price to Book Ratio1.53Price to Book Ratio
Enterprise Value to Revenue1.11
Enterprise Value to EBIT-362.33
Enterprise Value to Net Income-34
Total Debt to Enterprise0.59
Debt to Equity1.74Debt to Equity

Revenue Sources

No data

Last Earnings Call

Report Date
November 5, 2026
EPS
$0.29
Est. $0.31
Revenue
$836.00 M
Est. $861.68 M

Next Earnings Call

Expected Date
February 25, 2027
EPS Estimate
$0.29
Consensus analyst estimate
Revenue Estimate
$900.82 M
Consensus analyst estimate

Institutional Put/Call Ratio

Compares institutional put options with call options. At 0.00, the ratio is below 1, so institutions hold more calls than puts.

Put/Call Ratio0.0000▼ 76.57%
Total Calls93,100▼ 81.74%
Total Puts-▼ 100.00%

Institutional Ownership

Holdings and activity of institutional investors.

Ownership %17.33%▼ 96.91%
Total Invested$306.56M▼ 87.35%
Investors Holding160▼ 229.00%

About DENTSPLY Sirona Inc

14,000 employees
CEO: Bret Wise

DENTSPLY SIRONA Inc. is a global provider of diverse dental solutions, offering a comprehensive range of products and technologies to the professional dental industry across the globe. Its operations are segmented into two primary divisi...

DENTSPLY Sirona Insider Information FAQ

Stockcircle tracks 10 top investors with a current 13F position in DENTSPLY Sirona. Notable holders include ARK Invest and Bridgewater Associates. Holdings come from the latest quarterly 13F filings filed with the SEC.

In the latest 13F quarter on Stockcircle, 3 top investors increased or opened positions and 3 top investors reduced or sold among tracked top investors. Changes are based on reported share counts in their quarterly filings, not day-to-day trading.

Stockcircle shows 6 open-market insider purchases for DENTSPLY Sirona in the last six months from SEC Form 4 reports by executives, directors, and other insiders.

Form 4 insider trades are added as new filings are imported. Top investor 13F holdings refresh after each quarterly filing cycle. Politician trade disclosures are added when new reports are published on Stockcircle.